These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 11121838)
21. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Rosen RC; McKenna KE Annu Rev Sex Res; 2002; 13():36-88. PubMed ID: 12836729 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease. Conti CR; Pepine CJ; Sweeney M Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540 [TBL] [Abstract][Full Text] [Related]
23. Economic aspects of medical erectile dysfunction therapies. Anastasiadis AG; Ghafar MA; Burchardt M; Shabsigh R Expert Opin Pharmacother; 2002 Mar; 3(3):257-63. PubMed ID: 11866676 [TBL] [Abstract][Full Text] [Related]
24. Opportunities for the treatment of erectile dysfunction by modulation of the NO axis--alternatives to sildenafil citrate. de Mey C Curr Med Res Opin; 1998; 14(4):187-202. PubMed ID: 9891191 [TBL] [Abstract][Full Text] [Related]
25. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway. McAuley IW; Kim NN; Min K; Goldstein I; Traish AM J Androl; 2001; 22(4):623-8. PubMed ID: 11451359 [TBL] [Abstract][Full Text] [Related]
26. Erectile dysfunction and sildenafil citrate and cardiologists. Kloner RA; Jarow JP Am J Cardiol; 1999 Feb; 83(4):576-82, A7. PubMed ID: 10073864 [TBL] [Abstract][Full Text] [Related]
27. Erectile dysfunction: the Viagra revolution. Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258 [No Abstract] [Full Text] [Related]
28. Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. McCullough AR; Barada JH; Fawzy A; Guay AT; Hatzichristou D Urology; 2002 Sep; 60(2 Suppl 2):28-38. PubMed ID: 12414331 [TBL] [Abstract][Full Text] [Related]
29. [Erectile dysfunction: an update on new therapeutic options]. Roumeguère T Acta Urol Belg; 2000; 68(2):41-2. PubMed ID: 11098588 [No Abstract] [Full Text] [Related]
30. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Carson CC; Burnett AL; Levine LA; Nehra A Urology; 2002 Sep; 60(2 Suppl 2):12-27. PubMed ID: 12414330 [TBL] [Abstract][Full Text] [Related]
31. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Maggi M; Filippi S; Ledda F; Magini A; Forti G Eur J Endocrinol; 2000 Aug; 143(2):143-54. PubMed ID: 10913932 [TBL] [Abstract][Full Text] [Related]
32. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase. Kadioglu A; Grohmann W; Depko A; Levinson IP; Sun F; Collins S J Sex Med; 2008 Mar; 5(3):726-34. PubMed ID: 18086165 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacological therapy in erectile dysfunction--current standards and new viewpoint]. Schultheiss D; Stief CG; Truss MC; Jonas U Wien Med Wochenschr; 1997; 147(4-5):102-4. PubMed ID: 9190765 [TBL] [Abstract][Full Text] [Related]
35. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Boolell M; Allen MJ; Ballard SA; Gepi-Attee S; Muirhead GJ; Naylor AM; Osterloh IH; Gingell C Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389 [TBL] [Abstract][Full Text] [Related]
38. ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction. Eisenhardt A; Sperling H; Hauck E; Porst H; Stief C; Rübben H; Müller N; Siffert W Urology; 2003 Jul; 62(1):152-7. PubMed ID: 12837457 [TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit. Firoozi F; Longhurst PA; White MD BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142 [TBL] [Abstract][Full Text] [Related]